Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory Bowel disease

Laboratory Investigation

Volumn 78, Issue 12, 1998, Pages 1503-1512

  Peterson, Ron L ^a   Wang, LiLi ^a   Albert, Leo ^a   Keith Jr , James C ^a   Dorner, Andrew J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 1BETA; MYELOPEROXIDASE; RECOMBINANT INTERLEUKIN 11; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; ENTERITIS; ENZYME ACTIVITY; FECES ANALYSIS; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SPLEEN CELL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BETA 2-MICROGLOBULIN; CECUM; CELLS, CULTURED; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HLA-B27 ANTIGEN; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTERLEUKIN-11; INTERLEUKINS; LYMPHOCYTES; MALE; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032407805     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aiko S and Grisham MB (1995). Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 109:142-150.
2. Bank S, Sninsky C, Robinson M, Katz S, Singleton J, Miner P, Safdi M, Galandiuk S, Hanauer S, Varilek G, Sands B, Buchman A, Rogers V, Salzberg B, Cai B, Rogge H, and Schwertschlag US (1997). Safety and activity evaluation of rhIL-11 in subjects with active Crohn's disease. Gastroenterology 112(Suppl 1):A927.
3. Barnes PJ and Karin M (1997). Nuclear factor-kB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
4. Boughton-Smith N, Wallace J, Morris G, and Whittle BJ (1988). The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 94:65-72.
5. Bozza M, Kyvelos D, Trepicchio WL, Collins M, Klempner MS, and Dorner AJ (1998). rhIL-11 does not affect functions of purified human neutrophils in vitro. J Interferon Cytokine Res 18:889-895.
6. Braegger CP, Nicholls S, Murch SH, Stephens S, and MacDonald TT (1992). Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339:89-91.
7. Breban M, Fernandez-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, and Taurog JD (1996). T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 156:794-803.
8. Breban M, Hammer RE, Richardson JA, and Taurog JD (1993). Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 178:1607-1616.
9. Castagliuolo I, Kelly CP, Qiu BS, Nikulasson ST, LaMont JT, and Pothoulakis C (1997). IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum. Am J Physiol 273:G333-G341.
10. Czupryn M, Bennett F, Dube J, Grant K, Scoble H, Sookdeo H, and McCoy JM (1995). Alanine-scanning mutagenesis of human interleukin-11 : Identification of regions important for biological activity. Ann N Y Acad Sci 762:152-164.
11. Dijkema R, van der Meide PH, Pouwels PH, Caspers M, Dubbeld M, and Schellekens H (1985). Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J 4:761-767.
12. Dorner AJ, Goldman SJ, and Keith JC (1997). Interleukin-11: Biological activity and clinical studies. BioDrugs 8:418-429.
13. Du X, Liu Q, Yang Z, Orazi A, Rescorla FJ, Grosfeld JL, and Williams DA (1997). Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol 272:G545-G552.
14. Du X and Williams DA (1997). Interleukin-11 : Review of molecular, cell biology, and clinical use. Blood 89:3897-3908.
15. Du XX, Doerschuk CM, Orazi A, and Williams DA (1994). A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33-37.
16. Galea E, Reis DJ, and Feinstein DL (1994). Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J Neurosci Res 37:406-414.
17. Goldman SJ (1995). Preclinical biology of interleukin 11: A multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells (Dayt) 13:462-471.
18. Goodman RE, Oblak J, and Bell RG (1992). Synthesis and characterization of rat interleukin-10 (IL-10) cDNA clones from the RNA of cultured OX8-OX22-thoracic duct T cells. Bichem Biophys Res Commun 189:1-7.
19. Graham MF, Bryson GR, and Diegelmann RF (1990). Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 99:447-453.
20. Grisham MB, Benoit JN, and Granger DN (1990). Assessment of leukocyte involvement during ischemia and reperfusion of intestine. In: Packer L and Glazer AN, editors: Methods in enzymology. San Diego: Academic Press, Inc., 730-732.
21. Hammer RE, Maika SD, Richardson JA, Tang J-P, and Taurog JD (1990). Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: An animal model of HLA-B27-associated human disorders. Cell 63:1099-1112.
22. Issazadeh S, Ljungdahl A, Hojeberg B, Mustafa M, and Olsson T (1995). Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin-10, interleukin 12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J Neuroimmunol 61:205-212.
23. Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ, and Schaub RG (1994). IL-11, a pleiotropic cytokine: Exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells (Dayt) 12:79-89.
24. Krawisz, JE, Sharon P, and Stenson WF (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344-1350.
25. Mathieson PWA and Gillespie MK (1996). Cloning of a partial cDNA for rat interleukin-12 (IL-12) and analysis of IL-12 expression in vivo. J Immunol 44:11-14.
26. Matsushime H, Roussel MF, Matsushima K, Hishinuma A, and Sherr JC (1991). Cloning and expression of murine interleukin 1 receptor antagonist in macrophages stimulated by colony-stimulation factor 1. Blood 78:616-623.
27. McCabe RP, Secrist H, Botney M, Egan M, and Peters MG (1993). Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunolpathol 66:52-58.
28. McKnight AJ, Barclay AN, and Mason DW (1991). Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T Cells. Eur J Immunol 21:1187-1194.
29. McKnight AJ, Mason DW, and Braclay AN (1989). Sequence of rat interleukin 2 and anomalous binding of a mouse interleukin 2 cDNA probe to rat MHC class II-associated invariant chain mRNA. Immunogenetics 30:145-147.
30. Misra BR, Ferranti TJ, Donnelly LH, Erickson JE, Schaub RG, and Keith JC (1996). Recombinant human interleukin-11 prevents hypotension in LPS-treated anesthetized rabbits. J Endotox Res 3:297-305.
31. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, and MacDonald TT (1991). Serum concentrations of tumor necrosis factor α in childhood chronic inflammatory bowel disease. Gut 32:913-917.
32. Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, and Takeichi M (1987). Transformation of cell adhesion properties by exogenously introduced E-Cadherin cDNA. Nature 329:341-343.
33. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, and Strober W (1996). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kB abrogates established experimental colitis in mice. Nat Med 9:998-1004.
34. Nishida T, Nishino N, Takano M, Sekiguchi Y, Kawal K, Mizuno K, Nakai S, Masui Y, and Hiral Y (1989). Molecular cloning and expression of rat interleukin-1 alpha cDNA. J Biochem 105:351-357.
35. Northemann W, Braciak TA, Harrorl M, Lee F, and Fey GH (1989). Structure of the rat inteleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem 264:16072-16082.
36. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, and Yaffe D (1983). The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res 11:1759-1771.
37. Orazi A, Du X, Yang Z, Kashai M, and Williams DA (1996). Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75:33-42.
38. Peterson RL, Bozza MM, and Dorner AJ (1996). Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol 149:895-902.
39. Qiu BS, Pfeiffer CJ, and Keith JC Jr (1996). Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci 41:1625-1630.
40. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TEJ, Balish E, Taurog JD, Hammer RE, Wilson KH, and Sartor RB (1996). Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98:945-953.
41. Redlich CA, Gao X, Rockwell S, Kelley M, and Elias JA (1996). IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 157:1705-1710.
42. Reimund J-M, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindron P, and Duclos B (1996). Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 16:144-150.
43. Reinecker HC, Steffen M, Witthieft T, Pflueger I, Schreiber S, McDermott RP, and Raedler A (1993). Enhanced secretion of tumor necrosis factor-alpha, IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181.
44. Sartor RB (1994). Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 106:533-539.
45. Shirai T, Shimizu N, Shiojiri S, Horiguchi S, and Ito H (1988). Cloning and expression in Escherichia coli of the gene for mouse tumor necrosis factor. DNA 7:193-201.
46. Suemori S, Lynch-Devaney K, and Podolsky KK (1991). ldentificaion and characterization of rat intestinal trefoil factor: Tissue and cell specific member of the trefoil protein family. Proc Natl Acad Sci USA 88:11017-11021.
47. Trepicchio WL, Bozza M, Pedneault G, and Dorner AJ (1996). Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 157: 3627-3634.
48. Trepicchio WL, Wang L, Bozza M, and Dorner AJ (1997). IL-11 regulates macrophage effector function through inhibition of nuclear factor-kB. J Immunol 159:5661-5670.
49. Tso JY, Sun X-H, Reece KS, and Wu R (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502.
50. van Dulleman HM, van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, and Woody J (1995). Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody. Gastroenterology 109:129-135.